<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="EUR" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://iatistandard.org/203/schema/downloads/iati-activities-schema.xsd">
  <iati-identifier>NL-KVK-41207989-P-12001-2016014 - 2S4KN</iati-identifier>
  <reporting-org ref="NL-KVK-41207989" type="21">
   <narrative xml:lang="EN">Aidsfonds - Soaaids Nederland</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Epigenetic dissection of human genetic variation in HIV infection</narrative>
  </title>
  <description type="3">
   <narrative xml:lang="EN">0, there are no direct endusers of this project.
The enduses could be interpreted as the scientific community.</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">Host genetic variation has long been recognized to play a major role in HIV-1 infection susceptibility and disease progression. It is widely accepted that genetic variants in loci encoding class I human leukocyte antigens (HLA) and the chemokine receptor CCR5 have a major impact on HIV infection. The contribution of additional genetic variants remains elusive. In the past decade genome wide association studies (GWAS) have identified many single nucleotide polymorphisms that are statistically correlated with several aspects of HIV disease progression.  The significance of these genetic variants is currently not clear since the studies lack statistical power and many of the correlated variants locate to non-coding regions of the genome with unknown function. Previous studies comparing GWAS data with data obtained genome wide mapping of chromatin features have found that many phenotype associated SNPs locate to gene regulatory elements. This study will functionally characterize HIV associated non-coding SNPs. In particular it will test whether these SNPs alter the long-range transcriptional regulation of genes that could modulate the susceptibility to HIV infection. This study will provide mechanistic and functional insight into the contribution of host genetic variation to HIV infection and will identify novel disease-related target genes for therapy.</narrative>
  </description>
  <description type="4">
   <narrative xml:lang="EN">Host genetic variation has long been recognized to play a major role in HIV-1 infection susceptibility and disease progression. It is widely accepted that genetic variants in loci encoding class I human leukocyte antigens (HLA) and the chemokine receptor CCR5 have a major impact on HIV infection. The contribution of additional genetic variants remains elusive.</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN">This study will functionally characterize HIV associated non-coding SNPs. In particular it will test whether these SNPs alter the long-range transcriptional regulation of genes that could modulate the susceptibility to HIV infection. This study will provide mechanistic and functional insight into the contribution of host genetic variation to HIV infection and will identify novel disease-related target genes for new therapies, vaccination strategies and diagnostic tools.
Specific research questions: 
1. Do HIV associated SNPs locate to regulatory regions of the genome?
2.Which genes are controlled by these regulatory regions?
3. How do these genes contribute to the establishment and progression of HIV? Do the expression levels of genes that are controlled by the SNP containing regulatory elements indeed correlate with HIV infection?
4. What is the mechanism of attenuated regulation of the SNP containing regulatory elements? Which transcription factor binding sites are disrupted and what is the consequence of the altered binding of these transcription factors?
Output: all answers will be integrated into scientific publications.</narrative>
  </description>
  <participating-org ref="NL-KVK-41207989" role="1" type="22">
   <narrative xml:lang="EN">Aidsfonds Grants</narrative>
  </participating-org>
  <participating-org ref="NL-KVK-41207989" role="2" type="22">
   <narrative xml:lang="EN">Aidsfonds</narrative>
  </participating-org>
  <participating-org ref="NL-KVK-24485070" role="4" type="80">
   <narrative xml:lang="EN">EMC - Biochemistry</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2016-08-01" type="1"></activity-date>
  <activity-date iso-date="2019-08-01" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Aidsfonds - Soaaids Nederland</narrative>
   </organisation>
   <telephone>+31(0)206262669</telephone>
   <email>IATI@aidsfonds.nl</email>
  </contact-info>
  <sector code="13040" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Epigenetic dissection of human genetic variation in HIV infection STD control including HIV/AIDS</narrative>
  </sector>
  <policy-marker code="9" significance="1" vocabulary="1"></policy-marker>
  <collaboration-type code="3"></collaboration-type>
  <default-flow-type code="30"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="1" type="1">
   <period-start iso-date="2016-08-01"></period-start>
   <period-end iso-date="2019-08-01"></period-end>
   <value currency="EUR" value-date="2016-08-01">275000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2016-10-28"></transaction-date>
   <value currency="EUR" value-date="2016-10-28">74000</value>
   <description>
    <narrative xml:lang="EN">Kpl 106536-BMW</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-24485070">
    <narrative xml:lang="EN">EMC - Biochemistry</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-10-28"></transaction-date>
   <value currency="EUR" value-date="2016-10-28">74000</value>
   <description>
    <narrative xml:lang="EN">Kpl 106536-BMW</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-24485070">
    <narrative xml:lang="EN">EMC - Biochemistry</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-10-28"></transaction-date>
   <value currency="EUR" value-date="2017-10-28">74000</value>
   <description>
    <narrative xml:lang="EN">Kpl 106536-BMW</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-24485070">
    <narrative xml:lang="EN">EMC - Biochemistry</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-10-28"></transaction-date>
   <value currency="EUR" value-date="2017-10-28">74000</value>
   <description>
    <narrative xml:lang="EN">Kpl 106536-BMW</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-24485070">
    <narrative xml:lang="EN">EMC - Biochemistry</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2018-10-28"></transaction-date>
   <value currency="EUR" value-date="2018-10-28">72000</value>
   <description>
    <narrative xml:lang="EN">Kpl 106536-BMW</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-24485070">
    <narrative xml:lang="EN">EMC - Biochemistry</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-10-28"></transaction-date>
   <value currency="EUR" value-date="2018-10-28">72000</value>
   <description>
    <narrative xml:lang="EN">Kpl 106536-BMW</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-24485070">
    <narrative xml:lang="EN">EMC - Biochemistry</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-27"></transaction-date>
   <value currency="EUR" value-date="2020-04-27">55000</value>
   <description>
    <narrative xml:lang="EN">Kpl 106536-BMW</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-24485070">
    <narrative xml:lang="EN">EMC - Biochemistry</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="EUR" value-date="2020-04-28">55000</value>
   <description>
    <narrative xml:lang="EN">Kpl 106536-BMW</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-24485070">
    <narrative xml:lang="EN">EMC - Biochemistry</narrative>
   </receiver-org>
  </transaction>
 </iati-activity>
</iati-activities>
